Učitavanje...

Rosiglitazone Improves Insulin Sensitivity and Baroreflex Gain in Rats with Diet-Induced Obesity

Obesity decreases baroreflex gain (BRG); however, the mechanisms are unknown. We tested the hypothesis that impaired BRG is related to the concurrent insulin resistance, and, therefore, BRG would be improved after treatment with the insulin-sensitizing drug rosiglitazone. Male rats fed a high-fat di...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Zhao, Ding, McCully, Belinda H., Brooks, Virginia L.
Format: Artigo
Jezik:Inglês
Izdano: The American Society for Pharmacology and Experimental Therapeutics 2012
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3464031/
https://ncbi.nlm.nih.gov/pubmed/22815534
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.112.194738
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!